Back to Newsroom

Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results

Zug, Switzerland, March 22, 2018 – Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today provided a business update and announced financial results for the fourth quarter and full year ended December 31, 2017.